Total Receivables - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Total Receivables Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Total Receivables
€5m
CAGR 3-Years
37%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Receivables
€30.5m
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
23%
Nanobiotix SA
PAR:NANO
Total Receivables
€9.5m
CAGR 3-Years
35%
CAGR 5-Years
12%
CAGR 10-Years
19%
Innate Pharma SA
PAR:IPH
Total Receivables
€19.8m
CAGR 3-Years
77%
CAGR 5-Years
-10%
CAGR 10-Years
7%
Genfit SA
NASDAQ:GNFT
Total Receivables
€32.7m
CAGR 3-Years
40%
CAGR 5-Years
30%
CAGR 10-Years
66%
Eurobio Scientific SA
PAR:ALERS
Total Receivables
€31.6m
CAGR 3-Years
-17%
CAGR 5-Years
24%
CAGR 10-Years
15%

See Also

What is Maat Pharma SA's Total Receivables?
Total Receivables
5m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Total Receivables amounts to 5m EUR.

What is Maat Pharma SA's Total Receivables growth rate?
Total Receivables CAGR 5Y
37%

Over the last year, the Total Receivables growth was 8%. The average annual Total Receivables growth rates for Maat Pharma SA have been 37% over the past three years , 37% over the past five years .

Back to Top